Apotex Health Corp is on the rise, with shares up 1.80% in the latest trading session.
In today's trading, Apotex Health Corp (APTX.TO) closed at CA$38.37, reflecting a notable increase. This uptick comes amid strategic moves and growing interest in the pharmaceutical sector, showing that investors are confident in the company's future prospects.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeAdvertisement
Market cap
$8.62B
P/E
22.8x
52W high
$40.18
52W low
$26.05
1W change
-4.77%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 15.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.24
+15.5% Upside
Current Price
C$35.71
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
49.0%
Annualized
90-Day Vol
51.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$42.69
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$37.90 | C$32.00 – C$44.88 |
| 60 trading days | C$40.22 | C$31.67 – C$51.09 |
| 90 trading days | C$42.69 | C$31.85 – C$57.22 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a market cap nearing CA$8.8 billion and a P/E ratio of 22.80, Apotex Health Corp is positioning itself well in the competitive pharmaceutical landscape, making it an interesting option for growth-oriented investors.
Apotex Health Corp's stock rises by 1.80%
The stock's positive movement reflects growing investor interest and confidence in Apotex's strategic initiatives.
Bull case
The recent deal with Cumberland Pharmaceuticals could boost Apotex's market presence and product offerings, potentially driving future revenue growth.
Bear case
Despite today's gains, the pharmaceutical sector can be unpredictable. Any regulatory issues or market shifts could affect Apotex's stock performance.
Advertisement
Market Performance Overview
Apotex Health Corp's stock has seen a 1.80% increase in the last trading session, indicating positive sentiment among investors. With a closing price of CA$38.37, the company continues to attract attention in the pharmaceutical sector.
Strategic Developments
The recent completion of a strategic transaction with Cumberland Pharmaceuticals has positioned Apotex for potential growth. This move is expected to enhance its market offerings, further solidifying its presence in the competitive landscape.
Looking Ahead
Investors should keep an eye on Apotex's future announcements and developments. With a strong market cap and ongoing strategic initiatives, the company could present significant opportunities for growth in the coming months. For more insights, visit the Apotex stock page.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
